Better Decisions

Find out which events are the best for you and your team to attend

Go to Lodescore

Intelligence & Account Based Marketing

Profile companies, people, and topics with data on presentations, posters, sponsors and exhibitors

Go to Lodescore Analytics

Improve ROI

Access live dashboards for spend, savings, budget planning, and ROI measurements

See more

Did you know?

Each year in the United States there are an estimated 1.8 million conventions, conferences, trade shows, and exhibition meetings. In 2015, these events are estimated to attract 247 million participants with an estimated direct spending of $298 billion. When combined with other indirect effects, the conference industry contributes $393 billion annually to US GDP; estimates put this figure at over $1 trillion globally.

With all of the individual and company activities that happen at conferences, they are a rich data resource that can be used for business intelligence and pro-actively monitoring movements within a sector – from scientific innovation, to product launches, to new partnerships/relationships, to trending topics and new perspectives from thought leaders and domain experts. Private equity firms, investment banks, business development professionals, consulting groups, and academic institutions attend conferences to gather information to influence decisions tied to stock and portfolio investments, mergers and acquisitions, identification of new customers, and the development of new products and services.

Recent Posts

Drug Development: Hot and Not

Drug Development: What’s Hot? What’s Not? Acquisitions, technology, patient engagement, real world evidence, and artificial intelligence are hot trends transforming pharma.  A new option for drug-delivery captured investor attention at BIO 2017. An entirely new take on cardiovascular care could mean billions for Novartis. And yet, what’s not hot remains a global threat to health […]

Continue reading

Digital Health Drives Healthcare Transformation to the Fast Lane

Buckle up because digital health is speeding up innovation and transforming healthcare delivery. Acceleration of innovation is at hand. Clinical trials will be expedited and medical knowledge will grow exponentially. The inevitability of value-based care and provider concerns are driving efforts to make the mountains of health data useful. Trusted companies will enjoy expedited device […]

Continue reading

Opportunity for Amazon?

Who’s to blame for the high costs of drugs? Don’t be too quick to answer! Several US-based fraud cases and lawsuits are pointing fingers at many different players. While Mylan, ExpressScripts, and CVS Omnicare are trying to dig themselves out of trouble, Amazon is making moves to transform the way that consumers get access to […]

Continue reading